
Andrew Hopkins, Exscientia CEO (Exscientia)
Laying claim to another AI 'first,' Exscientia tees up an I/O drug for the clinic
In January 2020, Exscientia announced that a drug molecule to treat OCD invented by AI was set to enter clinical trials for the first time …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.